查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654411

尿液检查市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场进行预测，2025 年至 2030 年

Urinalysis Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Application (UTI Screening, Diabetes), By End Use (Hospitals, Clinical Laboratories), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

尿液检查市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球尿液检查市场规模预计到2030年将达到68.5亿美元，2025年至2030年期间的复合年增长率为7.83%。全球尿道结石盛行率上升将促进市场成长 根据 SHEA 杂誌发表的一项研究，2021 年，约 60% 至 70% 的尿液检查是针对没有胃肠道 (GU) 相关症状的患者进行的。

已开发市场和新兴市场老龄化人口的增加以及与老龄化相关的疾病的增加可能会对尿液检查市场的成长产生积极影响。根据世界卫生组织（WHO）的数据，老年人数将从2020年的10亿增加到2021年的14亿。老年人慢性病的早期诊断和管理推动了胆红素、酮、葡萄糖和肌酸酐检测的增加。这些测试是透过尿液检查进行的，预计将推动市场成长。

此外，接受肾臟或肝臟移植等移植手术的患者通常会建议在手术前进行尿液检查，以避免尿道感染（UTI）。根据器官共享联合网络的资料，2021 年美国进行了约 24,669 例肾臟移植、9,236 例肝臟移植和 3,817 例心臟移植。因此，预计移植手术的增加将推动市场成长。

公司正在采取联盟和策略伙伴关係等倡议来开发和销售技术先进的尿液检查产品。例如，2021 年 10 月，Sysmex 开始与 Inpeco 合作开发一流的自动尿液检查工作流程解决方案。本产品是在Sysmex的UN系列和Inpeco的FlexLab TM尿液检查解决方案的帮助下开发的。它是唯一完全开放的自动化系统，旨在帮助实验室优化工作流程支援并提供最佳的患者照护。

尿液检查市场报告重点

  • 就 2024 年的销售额而言，消耗品部门将占绝对收益占有率，达到 78.56%。这种主导地位归因于临床和医院实验室对试剂和试纸的需求不断增加和频繁购买。
  • 尿道感染筛检领域占据市场主导地位，到 2024 年的收益占有率为 24.07%。
  • 临床测试部分在 2024 年占据最高收益占有率，约 45.88%。这是因为这些实验室可以轻鬆接触患者并提供先进的产品。
  • 北美尿液检查市场将占据市场主导地位，到 2024 年将占据 37.9% 的最大收益占有率。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章尿液检查市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 尿液检查市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章尿液检查市场：产品、估计与趋势分析

  • 全球尿液检查市场：产品仪表板
  • 全球尿液检查市场：产品差异分析
  • 全球尿液检查市场按产品和收益
  • 装置
  • 生化尿液分析仪
    • 全自动生化分析仪
    • 半自动尿液沉渣分析仪
  • 全自动尿液沉渣分析仪
    • 显微镜尿液分析仪
    • 流式细胞技术尿液分析仪
  • 耗材
  • 量油尺
  • 试剂
  • 一次性的

第 5 章尿液检查市场：按应用分類的估计和趋势分析

  • 全球尿液检查市场：应用仪表板
  • 全球尿液检查市场：应用趋势分析
  • 全球尿液检查市场按应用和收益
  • 尿道感染
  • 糖尿病
  • 肾臟疾病
  • 高血压
  • 肝臟疾病
  • 其他的

第六章尿液检查市场：依最终用途的估计和趋势分析

  • 全球尿液检查市场：最终用途仪表板
  • 全球尿液检查市场：最终用途变异分析
  • 全球尿液检查市场按最终用途和收益
  • 医院
  • 实验室测试
  • 居家医疗
  • 研究与学术
  • 其他的

第 7 章尿液检查市场：按产品、应用和最终用途、区域进行的估计和趋势分析

  • 区域控制面板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 2024 年主要企业的市场占有率分析
    • Abbott
    • Sysmex Corporation
    • Siemens Healthineers AG
    • ACON Laboratories, Inc.
    • ARKRAY Inc.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Bio-Rad Laboratories, Inc.
Product Code: 978-1-68038-817-6

Urinalysis Market Growth & Trends:

The global urinalysis market size is expected to reach USD 6.85 billion by 2030, expanding at a CAGR of 7.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).

Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.

Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.

Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex's and FlexLab TM track of Inpeco's urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.

Urinalysis Market Report Highlights:

  • The consumables segment held the dominant revenue share of 78.56% in terms of revenue in 2024. This dominance can be attributed to the increasing demand and frequent purchases of reagents and dipsticks by clinical and hospital laboratories.
  • The urinary tract infection screening segment dominated the market and accounted for a revenue share of 24.07% in 2024, due to the rising incidence of UTIs worldwide.
  • The clinical laboratories segment accounted for the highest revenue share of around 45.88% in 2024. This can be attributed to their easy accessibility to patients and the availability of advanced products in these laboratories.
  • North America urinalysis market dominated the market and accounted for the largest revenue share of 37.9% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product, application and end-use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urinalysis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
      • 3.2.1.2. Technological advancements in urinalysis devices
      • 3.2.1.3. Rising geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced urinalysis equipment
  • 3.3. Urinalysis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Environmental landscape

Chapter 4. Urinalysis Market: Product Estimates & Trend Analysis

  • 4.1. Global Urinalysis Market: Product Dashboard
  • 4.2. Global Urinalysis Market: Product Movement Analysis
  • 4.3. Global Urinalysis Market by Product , Revenue
  • 4.4. Instruments
  • 4.5. Biochemical Urine Analyzer
    • 4.5.1. Biochemical urine analyzer market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Automated Biochemical Analyzers
      • 4.5.2.1. Automated biochemical analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Semi-automated Urine Sediment Analyzers
      • 4.5.3.1. Semi-automated urine sediment analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. Automated Urine Sediment Analyzers
    • 4.6.1. Automated urine sediment analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.2. Microscopic Urine Analyzers
      • 4.6.2.1. Microscopic urine analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.3. Flowcytometric Urine Analyzers
      • 4.6.3.1. Flowcytometric urine analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Consumables
  • 4.8. Dipsticks
    • 4.8.1. Dipsticks market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.9. Reagents
    • 4.9.1. Reagents market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.10. Disposables
    • 4.10.1. Disposables market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Urinalysis Market: Application Estimates & Trend Analysis

  • 5.1. Global Urinalysis Market: Application Dashboard
  • 5.2. Global Urinalysis Market: Application Movement Analysis
  • 5.3. Global Urinalysis Market by Application , Revenue
  • 5.4. UTI Screening
    • 5.4.1. UTI screening market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Diabetes
    • 5.5.1. Diabetes market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Kidney Disease
    • 5.6.1. Kidney disease market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Hypertension
    • 5.7.1. Hypertension market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.8. Liver Disease
    • 5.8.1. Liver disease market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Urinalysis Market: End Use Estimates & Trend Analysis

  • 6.1. Global Urinalysis Market: End Use Dashboard
  • 6.2. Global Urinalysis Market: End Use Movement Analysis
  • 6.3. Global Urinalysis Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Clinical Laboratories
    • 6.5.1. Clinical laboratories market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Home Care
    • 6.6.1. Home care market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.7. Research and Academics
    • 6.7.1. Research and academics market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Urinalysis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Sysmex Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Siemens Healthineers AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. ACON Laboratories, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. ARKRAY Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. F. Hoffmann-La Roche Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Quidel Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Bio-Rad Laboratories, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 4 Global Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 5 Global Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 6 Global Urinalysis, by Region, 2018 - 2030 (USD Billion)
  • Table 7 North America Urinalysis, by Country, 2018 - 2030 (USD Billion)
  • Table 8 North America Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 9 North America Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 10 North America Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 11 U.S. Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 12 U.S. Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 14 Canada Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 15 Canada Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 16 Canada Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 17 Mexico Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 18 Mexico Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 19 Mexico Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 20 Europe Urinalysis, by Country, 2018 - 2030 (USD Billion)
  • Table 21 Europe Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 22 Europe Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 23 Europe Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 24 Germany Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 25 Germany Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 26 Germany Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 27 UK Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 28 UK Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 29 UK Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 30 France Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 31 France Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 32 France Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 33 Italy Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 34 Italy Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 35 Italy Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 36 Spain Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 37 Spain Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 38 Spain Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 39 Denmark Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 40 Denmark Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 41 Denmark Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 42 Sweden Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 43 Sweden Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 44 Sweden Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 45 Norway Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 46 Norway Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 47 Norway Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific Urinalysis, by Country, 2018 - 2030 (USD Billion)
  • Table 49 Asia Pacific Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 52 China Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 53 China Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 54 China Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 55 Japan Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 56 Japan Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 57 Japan Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 58 India Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 59 India Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 60 India Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 61 South Korea Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 62 South Korea Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 63 South Korea Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 64 Australia Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 65 Australia Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 66 Australia Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 67 Thailand Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 68 Thailand Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 69 Thailand Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 70 Latin America Urinalysis, by Country, 2018 - 2030 (USD Billion)
  • Table 71 Latin America Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 72 Latin America Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 73 Latin America Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 74 Brazil Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 75 Brazil Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 76 Brazil Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 77 Argentina Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 78 Argentina Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 79 Argentina Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 80 Middle East & Africa Urinalysis, by Country, 2018 - 2030 (USD Billion)
  • Table 81 Middle East & Africa Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 82 Middle East & Africa Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 83 Middle East & Africa Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 84 South Africa Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 85 South Africa Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 86 South Africa Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 90 UAE Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 91 UAE Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 92 UAE Urinalysis, by End Use, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait Urinalysis, by Product, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait Urinalysis, by Application, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait Urinalysis, by End Use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Urinalysis Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Urinalysis Market: Product Movement Analysis
  • Fig. 16 Global Urinalysis Market, for Instruments, 2018 - 2030 (USD Billion)
  • Fig. 17 Global Urinalysis Market, for Biochemical Urine Analyzer, 2018 - 2030 (USD Billion)
  • Fig. 18 Global Urinalysis Market, for Automated Biochemical Analyzers, 2018 - 2030 (USD Billion)
  • Fig. 19 Global Urinalysis Market, for Semi-automated Urine Sediment Analyzers, 2018 - 2030 (USD Billion)
  • Fig. 20 Global Urinalysis Market, for Automated Urine Sediment Analyzers, 2018 - 2030 (USD Billion)
  • Fig. 21 Global Urinalysis Market, for Microscopic Urine Analyzers, 2018 - 2030 (USD Billion)
  • Fig. 22 Global Urinalysis Market, for Flowcytometric Urine Analyzers, 2018 - 2030 (USD Billion)
  • Fig. 23 Global Urinalysis Market, for Consumables, 2018 - 2030 (USD Billion)
  • Fig. 24 Global Urinalysis Market, for Dipsticks, 2018 - 2030 (USD Billion)
  • Fig. 25 Global Urinalysis Market, for Reagents, 2018 - 2030 (USD Billion)
  • Fig. 26 Global Urinalysis Market, for Disposables, 2018 - 2030 (USD Billion)
  • Fig. 27 Global Urinalysis Market, for Application, 2018 - 2030 (USD Billion)
  • Fig. 28 Global Urinalysis Market, for UTI Screening, 2018 - 2030 (USD Billion)
  • Fig. 29 Global Urinalysis Market, for Diabetes, 2018 - 2030 (USD Billion)
  • Fig. 30 Global Urinalysis Market, for Kidney Disease, 2018 - 2030 (USD Billion)
  • Fig. 31 Global Urinalysis Market, for Hypertension, 2018 - 2030 (USD Billion)
  • Fig. 32 Global Urinalysis Market, for Liver Disease, 2018 - 2030 (USD Billion)
  • Fig. 33 Global Urinalysis Market, for Others, 2018 - 2030 (USD Billion)
  • Fig. 34 Global Urinalysis Market: End Use Movement Analysis
  • Fig. 35 Global Urinalysis Market, for Hospitals, 2018 - 2030 (USD Billion)
  • Fig. 36 Global Urinalysis Market, for Clinical Laboratories, 2018 - 2030 (USD Billion)
  • Fig. 37 Global Urinalysis Market, for Home Care, 2018 - 2030 (USD Billion)
  • Fig. 38 Global Urinalysis Market, for Research and Academics, 2018 - 2030 (USD Billion)
  • Fig. 39 Global Urinalysis Market, for Others, 2018 - 2030 (USD Billion)
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 Regional Outlook, 2024 & 2030
  • Fig. 42 Global Urinalysis Market: Region Movement Analysis
  • Fig. 43 North America Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 44 U.S. Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Canada Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Mexico Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 47 Europe Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Germany Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UK Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 50 France Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 51 Italy Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 52 Spain Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 53 Denmark Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 54 Sweden Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 55 Norway Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 57 Japan Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 58 China Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 59 India Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 60 Australia Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 61 South Korea Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 62 Thailand Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 63 Latin America Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 64 Brazil Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 65 Argentina Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 66 Middle East and Africa Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 67 South Africa Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 68 Saudi Arabia Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 69 UAE Urinalysis Market, 2018 - 2030 (USD Billion)
  • Fig. 70 Kuwait Urinalysis Market, 2018 - 2030 (USD Billion)